Jiangsu Longfengtang Chinese Medicine

Jiangsu Longfengtang Chinese Medicine is a prominent subsidiary of the Yangtze River Pharmaceutical Group, serving as a specialized base for the modernization of Traditional Chinese Medicine (TCM). The company operates one of China's most advanced TCM manufacturing facilities, utilizing automated production lines and rigorous quality control to bridge ancient herbal wisdom with modern pharmaceutical standards. Its product portfolio features market-leading treatments such as Lanqin Oral Liquid and Suhuang Zhike Capsules, which address respiratory and inflammatory conditions. Longfengtang is a key player in China's Big Health industry, focusing on the entire value chain from herbal cultivation to clinical application and intelligent logistics.